Literature DB >> 1786486

Drug abuse potential evaluation in animals.

R L Balster1.   

Abstract

Animal laboratory studies can provide useful information concerning the potential of drugs for abuse. Over the past 50 years, methods have been developed for use with animal subjects which allow the evaluation of pharmacological properties of drugs which are particularly relevant to their abuse. The methods for preclinical drug abuse liability testing are reviewed under six heading: (1) establishment of the degree of pharmacological equivalence to known drugs of abuse, (2) drug discrimination studies, (3) tests of tolerance and cross-tolerance, (4) tests of physical dependence capacity, (5) drug self-administration tests of reinforcing effects, and (6) evaluation of toxicity and performance impairment at self-administered doses. Preclinical studies can be helpful early in drug development to select lead compounds with low abuse potential for further study. In the case of new or already marketed medications, animal testing can often compliment and extend abuse liability evaluation in human subjects. The results of abuse potential evaluation studies can be useful in making decisions about the possible need for regulation under national and international drug laws, and thus play an important role in drug abuse prevention.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1786486     DOI: 10.1111/j.1360-0443.1991.tb01747.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


  34 in total

1.  Blowing smoke: how cigarette manufacturers argued that nicotine is not addictive.

Authors:  J Sharfstein
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

Review 2.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

Review 3.  On the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse.

Authors:  Holly Barrett Waldron; Yifrah Kaminer
Journal:  Addiction       Date:  2004-11       Impact factor: 6.526

Review 4.  The neurocircuitry of addiction: an overview.

Authors:  M W Feltenstein; R E See
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

5.  Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones.

Authors:  Michael B Gatch; Cynthia M Taylor; Michael J Forster
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

6.  Abuse liability of the dietary supplement dimethylamylamine.

Authors:  Sean B Dolan; Michael B Gatch
Journal:  Drug Alcohol Depend       Date:  2014-11-25       Impact factor: 4.492

Review 7.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 8.  Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.

Authors:  Margaret Haney
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

9.  Binge self-administration and deprivation produces sensitization to the reinforcing effects of cocaine in rats.

Authors:  Drake Morgan; Mark A Smith; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2004-08-19       Impact factor: 4.530

10.  Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle.

Authors:  Robert E Vann; Laura E Wise; Stephen A Varvel; Scott D Philibin; D Matthew Walentiny; Joseph H Porter
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.